Skip to content

Whole body MRI

DEVICE17 trials

Sponsors

M.D. Anderson Cancer Center, Gustave Roussy, Cancer Campus, Grand Paris, Institute of Cancer Research, United Kingdom, University College London Hospitals, University Health Network, Toronto

Conditions

Atypical NeurofibromaAtypical NeurofibromatosisBody CompositionBreast CancerCancerCardiovascular (CV) RiskCarotid ArteriosclerosisHIV

Phase 2

Phase 3

Unknown Phase

Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
CompletedNCT00592462
M.D. Anderson Cancer CenterBreast Cancer
Start: 2007-12-31End: 2015-12-31Updated: 2016-10-27
Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
CompletedNCT01737255
Institute of Cancer Research, United KingdomLi-Fraumeni Syndrome
Start: 2012-10-31End: 2017-12-31Updated: 2022-03-31
18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
CompletedNCT01993160
University Health Network, TorontoProstate Cancer
Start: 2013-12-31End: 2016-12-31Updated: 2017-01-13
Whole Body PET-MRI in Paediatric and Adolescent Lymphoma
NCT02935348
University College, LondonLymphoma
Start: 2014-02-28End: 2017-05-31Target: 25Updated: 2016-10-17
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques
NCT02935816
University College, LondonProstate Cancer
Start: 2015-01-31End: 2018-01-31Target: 130Updated: 2016-10-18
Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
Active, not recruitingNCT02950987
Dana-Farber Cancer InstituteLi-Fraumeni Syndrome
Start: 2012-03-31End: 2027-12-31Target: 150Updated: 2026-01-07
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574
Brugmann University HospitalMetastatic Breastcancer
Start: 2016-12-13End: 2020-12-30Target: 50Updated: 2020-01-18
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
Active, not recruitingNCT03820778
Children's National Research InstituteAtypical Neurofibroma, Atypical Neurofibromatosis, Neurofibroma +3
Start: 2018-07-12End: 2022-08-01Updated: 2021-03-02
Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma
Not yet recruitingNCT05353907
Guy's and St Thomas' NHS Foundation TrustMyeloma
Start: 2022-06-30End: 2026-12-31Target: 78Updated: 2022-04-29
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
RecruitingNCT06931561
Inova Health Care ServicesCancer
Start: 2025-02-11End: 2028-09-30Target: 800Updated: 2026-02-27
Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference
Not yet recruitingNCT06988007
Cliniques universitaires Saint-Luc- Université Catholique de LouvainSarcoma
Start: 2025-07-01End: 2027-12-31Target: 122Updated: 2025-05-23
Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA
RecruitingNCT07230327
The First Affiliated Hospital with Nanjing Medical UniversitySpondyloarthritis (SpA), Whole-body MRI (WBMRI)
Start: 2022-01-01End: 2026-12-31Target: 100Updated: 2025-11-17
The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
Not yet recruitingNCT07284082
University of California, San FranciscoBody Composition, Cardiovascular (CV) Risk, Carotid Arteriosclerosis +2
Start: 2025-12-15End: 2030-03-01Target: 90Updated: 2025-12-17

Related Papers

Journal of Clinical Oncology2016-05-203 citations